speb/financial-data huggingface dataset:
CHCT cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: -3181000.00
CHCT income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -3181000.00
CHCT income_statement (annual, 2024-12-31) — Net Interest Income: -23176000.00
CHCT cash_flow (annual, 2024-12-31) — Net Investment Properties Purchase And Sale: -70067000.00
CHCT cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: 82180000.00
CHCT cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: 82180000.00
CHCT income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: -23176000.00
CHCT cash_flow (annual, 2024-12-31) — Net Other Financing Charges: -4441000.00
CHCT cash_flow (annual, 2024-12-31) — Net Other Investing Changes: 2048000.00
CHCT balance_sheet (annual, 2024-12-31) — Net PPE: 3125000.00
CHCT balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 474033000.00
CHCT balance_sheet (annual, 2024-12-31) — Non Current Deferred Assets: 3725000.00
CHCT income_statement (annual, 2024-12-31) — Normalized EBITDA: 64351000.00
CHCT income_statement (annual, 2024-12-31) — Normalized Income: -3065808.00
CHCT balance_sheet (annual, 2024-12-31) — Notes Receivable: 17727000.00
CHCT cash_flow (annual, 2024-12-31) — Operating Cash Flow: 58881000.00
CHCT cash_flow (annual, 2024-12-31) — Operating Gains Losses: 121000.00
CHCT income_statement (annual, 2024-12-31) — Operating Income: 20116000.00
CHCT income_statement (annual, 2024-12-31) — Operating Revenue: 115786000.00
CHCT balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 28242370.00
CHCT balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: -314516000.00
CHCT income_statement (annual, 2024-12-31) — Other Gand A: 19058000.00
CHCT income_statement (annual, 2024-12-31) — Other Income Expense: -121000.00
CHCT income_statement (quarterly, 2024-12-31) — Other Income Expense: 14000.00
CHCT balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 1932000.00
CHCT cash_flow (annual, 2024-12-31) — Other Non Cash Items: -1942000.00
CHCT balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 4720000.00
CHCT balance_sheet (annual, 2024-12-31) — Other Non Current Liabilities: 5825000.00
CHCT balance_sheet (annual, 2024-12-31) — Other Properties: 3125000.00
CHCT balance_sheet (annual, 2024-12-31) — Other Receivables: 3012000.00
CHCT income_statement (annual, 2024-12-31) — Otherunder Preferred Stock Dividend: 2795000.00
CHCT balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 14289000.00
CHCT balance_sheet (annual, 2024-12-31) — Preferred Stock: 0.00
CHCT balance_sheet (annual, 2024-12-31) — Prepaid Assets: 1666000.00
CHCT income_statement (annual, 2024-12-31) — Pretax Income: -3181000.00
CHCT income_statement (annual, 2024-12-31) — Provision For Doubtful Accounts: 11000000.00
CHCT income_statement (quarterly, 2024-12-31) — Provision For Doubtful Accounts: 0.00
CHCT cash_flow (annual, 2024-12-31) — Provisionand Write Offof Assets: 11000000.00
CHCT cash_flow (quarterly, 2024-12-31) — Provisionand Write Offof Assets: 0.00
CHCT cash_flow (annual, 2024-12-31) — Purchase Of Investment Properties: -72368000.00
CHCT balance_sheet (annual, 2024-12-31) — Receivables: 45303000.00
CHCT income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 21907000.00
CHCT income_statement (annual, 2024-12-31) — Reconciled Depreciation: 43705000.00
CHCT cash_flow (annual, 2024-12-31) — Repayment Of Debt: -79820000.00
CHCT cash_flow (quarterly, 2024-12-31) — Repayment Of Debt: -75000000.00
CHCT balance_sheet (annual, 2024-12-31) — Restricted Cash: 0.00
CHCT balance_sheet (quarterly, 2024-12-31) — Restricted Cash: 0.00
CHCT balance_sheet (annual, 2024-12-31) — Retained Earnings: 85675000.00
CHCT cash_flow (annual, 2024-12-31) — Sale Of Investment Properties: 2301000.00
CHCT income_statement (annual, 2024-12-31) — Selling General And Administration: 19058000.00
CHCT balance_sheet (annual, 2024-12-31) — Share Issued: 28242370.00
CHCT income_statement (annual, 2024-12-31) — Special Income Charges: -121000.00
CHCT cash_flow (annual, 2024-12-31) — Stock Based Compensation: 9987000.00
CHCT balance_sheet (annual, 2024-12-31) — Stockholders Equity: 475965000.00
CHCT balance_sheet (annual, 2024-12-31) — Tangible Book Value: 474033000.00
CHCT income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: -5808.00
CHCT income_statement (annual, 2024-12-31) — Tax Provision: 0.00
CHCT income_statement (quarterly, 2024-12-31) — Tax Provision: 0.00
CHCT income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.05
CHCT balance_sheet (annual, 2024-12-31) — Total Assets: 992563000.00
CHCT balance_sheet (annual, 2024-12-31) — Total Capitalization: 749920000.00
CHCT balance_sheet (annual, 2024-12-31) — Total Debt: 489980000.00
CHCT balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 475965000.00
CHCT income_statement (annual, 2024-12-31) — Total Expenses: 95670000.00
CHCT balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 516598000.00
CHCT balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 934455000.00
CHCT balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 283805000.00
CHCT income_statement (annual, 2024-12-31) — Total Unusual Items: -121000.00
CHCT income_statement (quarterly, 2024-12-31) — Total Unusual Items: 14000.00
CHCT income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: -121000.00
CHCT income_statement (quarterly, 2024-12-31) — Total Unusual Items Excluding Goodwill: 14000.00
CHCT balance_sheet (annual, 2024-12-31) — Working Capital: -174685000.00
CHCT income_statement (quarterly, 2025-03-31) — +Operating Expense: 16043000.00
CHCT income_statement (quarterly, 2025-03-31) — +Total Revenue: 30078000.00
CHCT balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 24492000.00
CHCT balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 706776000.00
CHCT cash_flow (quarterly, 2025-03-31) — Amortization Cash Flow: 345000.00
CHCT cash_flow (quarterly, 2025-03-31) — Amortization Of Intangibles: 345000.00
CHCT balance_sheet (quarterly, 2025-03-31) — Assets Held For Sale Current: 6755000.00
CHCT income_statement (quarterly, 2025-03-31) — Basic Average Shares: 26733000.00
CHCT income_statement (quarterly, 2025-03-31) — Basic EPS: 0.03
CHCT cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 4384000.00
CHCT cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -4682000.00
CHCT cash_flow (quarterly, 2025-03-31) — Capital Expenditure Reported: -4682000.00
CHCT balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 4018000.00
CHCT balance_sheet (quarterly, 2025-03-31) — Capital Stock: 283000.00
CHCT balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 2271000.00
CHCT balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 2271000.00
CHCT cash_flow (quarterly, 2025-03-31) — Cash Dividends Paid: -13259000.00
CHCT cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -3931000.00
CHCT cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -12591000.00
CHCT cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: 14409000.00
CHCT cash_flow (quarterly, 2025-03-31) — Change In Other Current Assets: 213000.00
CHCT cash_flow (quarterly, 2025-03-31) — Change In Other Current Liabilities: -391000.00
CHCT cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -363000.00
CHCT cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -541000.00
CHCT cash_flow (quarterly, 2025-03-31) — Changes In Cash: -2113000.00
CHCT balance_sheet (quarterly, 2025-03-31) — Common Stock: 283000.00
CHCT balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 461321000.00
CHCT cash_flow (quarterly, 2025-03-31) — Common Stock Issuance: 0.00
CHCT income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 6095000.00
CHCT balance_sheet (quarterly, 2025-03-31) — Current Assets: 63684000.00
CHCT balance_sheet (quarterly, 2025-03-31) — Current Debt: 222000000.00
CHCT balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 222000000.00
CHCT balance_sheet (quarterly, 2025-03-31) — Current Deferred Liabilities: 5757000.00
CHCT balance_sheet (quarterly, 2025-03-31) — Current Deferred Revenue: 5757000.00
CHCT balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 239815000.00
CHCT cash_flow (quarterly, 2025-03-31) — Depreciation: 10943000.00
CHCT cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 11288000.00
CHCT income_statement (quarterly, 2025-03-31) — Depreciation Amortization Depletion Income Statement: 10943000.00
CHCT cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 11288000.00
CHCT income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 10943000.00
CHCT income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 26733000.00
CHCT income_statement (quarterly, 2025-03-31) — Diluted EPS: 0.03
CHCT income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 833000.00
CHCT income_statement (quarterly, 2025-03-31) — EBIT: 7943000.00
CHCT income_statement (quarterly, 2025-03-31) — EBITDA: 19231000.00
CHCT cash_flow (quarterly, 2025-03-31) — End Cash Position: 2271000.00
CHCT balance_sheet (quarterly, 2025-03-31) — Financial Assets: 12402000.00
CHCT cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -3931000.00
CHCT cash_flow (quarterly, 2025-03-31) — Free Cash Flow: 9727000.00
CHCT balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: -333004000.00
CHCT income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 5100000.00
CHCT balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 1769000.00
CHCT balance_sheet (quarterly, 2025-03-31) — Gross PPE: 3102000.00
CHCT income_statement (quarterly, 2025-03-31) — Gross Profit: 23983000.00
CHCT cash_flow (quarterly, 2025-03-31) — Income Tax Paid Supplemental Data: 20000.00
CHCT income_statement (quarterly, 2025-03-31) — Interest Expense: 6352000.00
CHCT income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 6352000.00
CHCT income_statement (quarterly, 2025-03-31) — Interest Income: 3000.00
CHCT income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 3000.00
CHCT cash_flow (quarterly, 2025-03-31) — Interest Paid Supplemental Data: 6088000.00
CHCT balance_sheet (quarterly, 2025-03-31) — Invested Capital: 957337000.00
CHCT cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -12591000.00
CHCT balance_sheet (quarterly, 2025-03-31) — Investment Properties: 895235000.00
CHCT cash_flow (quarterly, 2025-03-31) — Issuance Of Capital Stock: 0.00
CHCT cash_flow (quarterly, 2025-03-31) — Issuance Of Debt: 10000000.00
CHCT balance_sheet (quarterly, 2025-03-31) — Line Of Credit: 222000000.00
CHCT balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 4018000.00
CHCT balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 274016000.00
CHCT balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 278034000.00
CHCT cash_flow (quarterly, 2025-03-31) — Long Term Debt Issuance: 10000000.00
CHCT cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: 0.00
CHCT cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: 0.00
CHCT balance_sheet (quarterly, 2025-03-31) — Net Debt: 493745000.00
CHCT income_statement (quarterly, 2025-03-31) — Net Income: 1591000.00
CHCT income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 833000.00
CHCT income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 1591000.00
CHCT income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 1591000.00
CHCT income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 1591000.00
CHCT cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 1591000.00
CHCT income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 1591000.00
CHCT income_statement (quarterly, 2025-03-31) — Net Interest Income: -6349000.00
CHCT cash_flow (quarterly, 2025-03-31) — Net Investment Properties Purchase And Sale: 0.00
CHCT cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: -9711000.00
CHCT cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: 10000000.00
CHCT cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: 10000000.00
CHCT income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -6349000.00
CHCT cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: -672000.00
CHCT cash_flow (quarterly, 2025-03-31) — Net Other Investing Changes: 1802000.00
CHCT balance_sheet (quarterly, 2025-03-31) — Net PPE: 3102000.00
CHCT balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 459552000.00
CHCT balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Assets: 3531000.00
CHCT income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 19231000.00
CHCT income_statement (quarterly, 2025-03-31) — Normalized Income: 1591000.00
CHCT balance_sheet (quarterly, 2025-03-31) — Notes Receivable: 15925000.00
CHCT cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: 14409000.00
CHCT income_statement (quarterly, 2025-03-31) — Operating Income: 7940000.00
CHCT income_statement (quarterly, 2025-03-31) — Operating Revenue: 30078000.00
CHCT balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 28338690.00
CHCT balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: -333004000.00
CHCT income_statement (quarterly, 2025-03-31) — Other Gand A: 5100000.00
CHCT balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 1769000.00
CHCT cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: -639000.00
CHCT balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 5391000.00
CHCT balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 5944000.00
CHCT balance_sheet (quarterly, 2025-03-31) — Other Properties: 3102000.00
CHCT balance_sheet (quarterly, 2025-03-31) — Other Receivables: 12725000.00
CHCT income_statement (quarterly, 2025-03-31) — Otherunder Preferred Stock Dividend: 758000.00
CHCT balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 12058000.00
CHCT balance_sheet (quarterly, 2025-03-31) — Preferred Stock: 0.00
CHCT balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 1516000.00
CHCT income_statement (quarterly, 2025-03-31) — Pretax Income: 1591000.00
CHCT cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: -9711000.00
CHCT cash_flow (quarterly, 2025-03-31) — Purchase Of Investment Properties: 0.00
CHCT balance_sheet (quarterly, 2025-03-31) — Receivables: 53142000.00
CHCT income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 5750000.00
CHCT income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 11288000.00
CHCT cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: 0.00
CHCT balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 87266000.00
CHCT cash_flow (quarterly, 2025-03-31) — Sale Of Investment Properties: 0.00
CHCT income_statement (quarterly, 2025-03-31) — Selling General And Administration: 5100000.00
CHCT balance_sheet (quarterly, 2025-03-31) — Share Issued: 28338690.00
CHCT cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 2710000.00
CHCT balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 461321000.00
CHCT balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 459552000.00
CHCT income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
CHCT income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.21
CHCT balance_sheet (quarterly, 2025-03-31) — Total Assets: 985114000.00
CHCT balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 735337000.00
CHCT balance_sheet (quarterly, 2025-03-31) — Total Debt: 500034000.00
CHCT balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 461321000.00
CHCT income_statement (quarterly, 2025-03-31) — Total Expenses: 22138000.00
CHCT balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 523793000.00
CHCT balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 921430000.00
CHCT balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 283978000.00
CHCT balance_sheet (quarterly, 2025-03-31) — Working Capital: -176131000.00
CHCT income_statement (quarterly, 2025-06-30) — +Operating Expense: 24210000.00
CHCT income_statement (quarterly, 2025-06-30) — +Total Revenue: 29085000.00
CHCT balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 23957000.00
CHCT balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 712498000.00
CHCT cash_flow (quarterly, 2025-06-30) — Amortization Cash Flow: 199000.00
CHCT cash_flow (quarterly, 2025-06-30) — Amortization Of Intangibles: 199000.00
CHCT balance_sheet (quarterly, 2025-06-30) — Assets Held For Sale Current: 5465000.00
CHCT income_statement (quarterly, 2025-06-30) — Basic Average Shares: 26803000.00
CHCT income_statement (quarterly, 2025-06-30) — Basic EPS: -0.50
CHCT cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 2271000.00
CHCT cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -4229000.00
CHCT cash_flow (quarterly, 2025-06-30) — Capital Expenditure Reported: -4229000.00
CHCT balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 4010000.00
CHCT balance_sheet (quarterly, 2025-06-30) — Capital Stock: 284000.00
CHCT balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 4863000.00
CHCT balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 4863000.00
CHCT cash_flow (quarterly, 2025-06-30) — Cash Dividends Paid: -13386000.00
CHCT cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -10766000.00
CHCT cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -441000.00
CHCT cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 13799000.00
CHCT cash_flow (quarterly, 2025-06-30) — Change In Other Current Assets: 1455000.00
CHCT cash_flow (quarterly, 2025-06-30) — Change In Other Current Liabilities: -1068000.00
CHCT cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 921000.00
CHCT cash_flow (quarterly, 2025-06-30) — Change In Working Capital: 1308000.00
CHCT cash_flow (quarterly, 2025-06-30) — Changes In Cash: 2592000.00
CHCT balance_sheet (quarterly, 2025-06-30) — Common Stock: 284000.00
CHCT balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 437820000.00
CHCT cash_flow (quarterly, 2025-06-30) — Common Stock Issuance: 0.00
CHCT income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 5585000.00
CHCT balance_sheet (quarterly, 2025-06-30) — Current Assets: 48319000.00
CHCT balance_sheet (quarterly, 2025-06-30) — Current Debt: 226000000.00
CHCT balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 226000000.00
CHCT balance_sheet (quarterly, 2025-06-30) — Current Deferred Liabilities: 5813000.00
CHCT balance_sheet (quarterly, 2025-06-30) — Current Deferred Revenue: 5813000.00
CHCT balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 245757000.00
CHCT cash_flow (quarterly, 2025-06-30) — Depreciation: 10879000.00
CHCT cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 11078000.00
CHCT income_statement (quarterly, 2025-06-30) — Depreciation Amortization Depletion Income Statement: 10879000.00
CHCT cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 11078000.00
CHCT income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 10879000.00
CHCT income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 26803000.00
CHCT income_statement (quarterly, 2025-06-30) — Diluted EPS: -0.50
CHCT income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -13327000.00
CHCT income_statement (quarterly, 2025-06-30) — EBIT: -5965000.00
CHCT income_statement (quarterly, 2025-06-30) — EBITDA: 5113000.00
CHCT cash_flow (quarterly, 2025-06-30) — End Cash Position: 4863000.00
CHCT balance_sheet (quarterly, 2025-06-30) — Financial Assets: 9121000.00
CHCT cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -10766000.00
CHCT cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 9570000.00
CHCT income_statement (quarterly, 2025-06-30) — Gain On Sale Of Security: 640000.00
CHCT balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: -349671000.00
CHCT income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 4659000.00
CHCT balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 1625000.00
CHCT balance_sheet (quarterly, 2025-06-30) — Gross PPE: 3080000.00
CHCT income_statement (quarterly, 2025-06-30) — Gross Profit: 23500000.00
CHCT cash_flow (quarterly, 2025-06-30) — Income Tax Paid Supplemental Data: 0.00
CHCT income_statement (quarterly, 2025-06-30) — Interest Expense: 6592000.00
CHCT income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 6592000.00
CHCT income_statement (quarterly, 2025-06-30) — Interest Income: 5000.00
CHCT income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 5000.00
CHCT cash_flow (quarterly, 2025-06-30) — Interest Paid Supplemental Data: 6332000.00
CHCT balance_sheet (quarterly, 2025-06-30) — Invested Capital: 937897000.00
CHCT cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -441000.00
CHCT balance_sheet (quarterly, 2025-06-30) — Investment Properties: 895351000.00
CHCT cash_flow (quarterly, 2025-06-30) — Issuance Of Capital Stock: 0.00
CHCT cash_flow (quarterly, 2025-06-30) — Issuance Of Debt: 4000000.00
CHCT balance_sheet (quarterly, 2025-06-30) — Line Of Credit: 226000000.00
CHCT balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 4010000.00
CHCT balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 274077000.00
CHCT balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 278087000.00
CHCT cash_flow (quarterly, 2025-06-30) — Long Term Debt Issuance: 4000000.00
CHCT cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: 0.00
CHCT cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: 0.00
CHCT balance_sheet (quarterly, 2025-06-30) — Net Debt: 495214000.00
CHCT income_statement (quarterly, 2025-06-30) — Net Income: -12557000.00
CHCT income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -13327000.00
CHCT income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -12557000.00
CHCT income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -12557000.00
CHCT income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -12557000.00
CHCT cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: -12557000.00
CHCT income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -12557000.00
CHCT income_statement (quarterly, 2025-06-30) — Net Interest Income: -6587000.00
CHCT cash_flow (quarterly, 2025-06-30) — Net Investment Properties Purchase And Sale: -9096000.00
CHCT cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: 4000000.00
CHCT cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: 4000000.00
CHCT income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -6587000.00
CHCT cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: -1380000.00
CHCT cash_flow (quarterly, 2025-06-30) — Net Other Investing Changes: 3173000.00
CHCT balance_sheet (quarterly, 2025-06-30) — Net PPE: 3080000.00
CHCT balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 436195000.00
CHCT balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Assets: 3336000.00
CHCT income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 10373000.00
CHCT income_statement (quarterly, 2025-06-30) — Normalized Income: -7297000.00
CHCT balance_sheet (quarterly, 2025-06-30) — Notes Receivable: 4080000.00
CHCT cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 13799000.00
CHCT income_statement (quarterly, 2025-06-30) — Operating Income: -710000.00
CHCT income_statement (quarterly, 2025-06-30) — Operating Revenue: 29085000.00
CHCT balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 28368353.00
CHCT balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: -349671000.00
CHCT income_statement (quarterly, 2025-06-30) — Other Gand A: 2159000.00
CHCT income_statement (quarterly, 2025-06-30) — Other Income Expense: -5260000.00
CHCT balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 1625000.00
CHCT cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: -1184000.00
CHCT balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 5460000.00
CHCT balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 4628000.00
CHCT balance_sheet (quarterly, 2025-06-30) — Other Properties: 3080000.00
CHCT balance_sheet (quarterly, 2025-06-30) — Other Receivables: 8004000.00
CHCT income_statement (quarterly, 2025-06-30) — Otherunder Preferred Stock Dividend: 770000.00
CHCT balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 13944000.00
CHCT balance_sheet (quarterly, 2025-06-30) — Preferred Stock: 0.00
CHCT balance_sheet (quarterly, 2025-06-30) — Prepaid Assets: 1950000.00
CHCT income_statement (quarterly, 2025-06-30) — Pretax Income: -12557000.00
CHCT income_statement (quarterly, 2025-06-30) — Provision For Doubtful Accounts: 8672000.00
CHCT cash_flow (quarterly, 2025-06-30) — Purchase Of Investment Properties: -9711000.00
CHCT balance_sheet (quarterly, 2025-06-30) — Receivables: 36041000.00
CHCT income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 5386000.00
CHCT income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 11078000.00
CHCT cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: 0.00
CHCT income_statement (quarterly, 2025-06-30) — Restructuring And Mergern Acquisition: 5900000.00
CHCT balance_sheet (quarterly, 2025-06-30) — Retained Earnings: 74709000.00
CHCT income_statement (quarterly, 2025-06-30) — Salaries And Wages: 2500000.00
CHCT cash_flow (quarterly, 2025-06-30) — Sale Of Investment Properties: 615000.00
CHCT income_statement (quarterly, 2025-06-30) — Selling General And Administration: 4659000.00
CHCT balance_sheet (quarterly, 2025-06-30) — Share Issued: 28368353.00
CHCT income_statement (quarterly, 2025-06-30) — Special Income Charges: -5900000.00
CHCT cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 7122000.00
CHCT balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 437820000.00
CHCT balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 436195000.00
CHCT income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
CHCT income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.00
CHCT balance_sheet (quarterly, 2025-06-30) — Total Assets: 966292000.00
CHCT balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 711897000.00
CHCT balance_sheet (quarterly, 2025-06-30) — Total Debt: 504087000.00
CHCT balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 437820000.00
CHCT income_statement (quarterly, 2025-06-30) — Total Expenses: 29795000.00
CHCT balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 528472000.00
CHCT balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 917973000.00
CHCT balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 282715000.00
CHCT income_statement (quarterly, 2025-06-30) — Total Unusual Items: -5260000.00
CHCT income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: -5260000.00
CHCT balance_sheet (quarterly, 2025-06-30) — Working Capital: -197438000.00
CHCT income_statement (quarterly, 2025-09-30) — +Operating Expense: 15560000.00
CHCT income_statement (quarterly, 2025-09-30) — +Total Revenue: 31086000.00
CHCT balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 24734000.00
CHCT balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 714890000.00
CHCT cash_flow (quarterly, 2025-09-30) — Amortization Cash Flow: 361000.00
CHCT cash_flow (quarterly, 2025-09-30) — Amortization Of Intangibles: 361000.00
CHCT balance_sheet (quarterly, 2025-09-30) — Assets Held For Sale Current: 6205000.00
CHCT income_statement (quarterly, 2025-09-30) — Basic Average Shares: 26934000.00
CHCT income_statement (quarterly, 2025-09-30) — Basic EPS: 0.03
CHCT cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 4863000.00
CHCT cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -5076000.00
CHCT cash_flow (quarterly, 2025-09-30) — Capital Expenditure Reported: -5076000.00
CHCT balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 4003000.00
CHCT balance_sheet (quarterly, 2025-09-30) — Capital Stock: 285000.00
CHCT balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 3383000.00
CHCT balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 3383000.00
CHCT cash_flow (quarterly, 2025-09-30) — Cash Dividends Paid: -13477000.00
CHCT cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: 16466000.00
CHCT cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -30668000.00
CHCT cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 12722000.00
CHCT cash_flow (quarterly, 2025-09-30) — Change In Other Current Assets: -453000.00
CHCT cash_flow (quarterly, 2025-09-30) — Change In Other Current Liabilities: -1382000.00
CHCT cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: -786000.00
CHCT cash_flow (quarterly, 2025-09-30) — Change In Working Capital: -2621000.00
CHCT cash_flow (quarterly, 2025-09-30) — Changes In Cash: -1480000.00
CHCT balance_sheet (quarterly, 2025-09-30) — Common Stock: 285000.00
CHCT balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 426823000.00
CHCT cash_flow (quarterly, 2025-09-30) — Common Stock Issuance: 0.00
CHCT income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 5930000.00
CHCT balance_sheet (quarterly, 2025-09-30) — Current Assets: 48411000.00
CHCT balance_sheet (quarterly, 2025-09-30) — Current Debt: 256000000.00
CHCT balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 256000000.00
CHCT balance_sheet (quarterly, 2025-09-30) — Current Deferred Liabilities: 4661000.00
CHCT balance_sheet (quarterly, 2025-09-30) — Current Deferred Revenue: 4661000.00
CHCT balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 277866000.00
CHCT cash_flow (quarterly, 2025-09-30) — Depreciation: 10902000.00
CHCT cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 11263000.00
CHCT income_statement (quarterly, 2025-09-30) — Depreciation Amortization Depletion Income Statement: 10902000.00
CHCT cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 11263000.00
CHCT income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 10902000.00
CHCT balance_sheet (quarterly, 2025-09-30) — Derivative Product Liabilities: 12000.00
CHCT income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 26934000.00
CHCT income_statement (quarterly, 2025-09-30) — Diluted EPS: 0.03
CHCT income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 890000.00
CHCT income_statement (quarterly, 2025-09-30) — EBIT: 8715000.00
CHCT income_statement (quarterly, 2025-09-30) — EBITDA: 19978000.00
CHCT cash_flow (quarterly, 2025-09-30) — End Cash Position: 3383000.00
CHCT balance_sheet (quarterly, 2025-09-30) — Financial Assets: 7580000.00
CHCT cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: 16466000.00
CHCT cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 7646000.00
CHCT cash_flow (quarterly, 2025-09-30) — Gain Loss On Investment Securities: 888000.00
CHCT income_statement (quarterly, 2025-09-30) — Gain On Sale Of Security: -888000.00
CHCT balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: -364701000.00
CHCT income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 4658000.00
CHCT balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 1483000.00
CHCT balance_sheet (quarterly, 2025-09-30) — Gross PPE: 3058000.00
CHCT income_statement (quarterly, 2025-09-30) — Gross Profit: 25156000.00
CHCT cash_flow (quarterly, 2025-09-30) — Income Tax Paid Supplemental Data: 0.00
CHCT income_statement (quarterly, 2025-09-30) — Interest Expense: 7075000.00
CHCT income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 7075000.00
CHCT income_statement (quarterly, 2025-09-30) — Interest Income: 7000.00
CHCT income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 7000.00
CHCT cash_flow (quarterly, 2025-09-30) — Interest Paid Supplemental Data: 6812000.00
CHCT balance_sheet (quarterly, 2025-09-30) — Invested Capital: 956961000.00
CHCT cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -30668000.00
CHCT balance_sheet (quarterly, 2025-09-30) — Investment Properties: 917670000.00
CHCT cash_flow (quarterly, 2025-09-30) — Issuance Of Capital Stock: 0.00
CHCT cash_flow (quarterly, 2025-09-30) — Issuance Of Debt: 30000000.00
CHCT balance_sheet (quarterly, 2025-09-30) — Line Of Credit: 256000000.00
CHCT balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 4003000.00
CHCT balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 274138000.00
CHCT balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 278141000.00
CHCT cash_flow (quarterly, 2025-09-30) — Long Term Debt Issuance: 30000000.00
CHCT cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: 0.00
CHCT cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: 0.00
CHCT balance_sheet (quarterly, 2025-09-30) — Net Debt: 526755000.00
CHCT income_statement (quarterly, 2025-09-30) — Net Income: 1640000.00
CHCT income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 890000.00
CHCT income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 1640000.00
CHCT income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 1640000.00
CHCT income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 1640000.00
CHCT cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 1640000.00
CHCT income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 1640000.00
CHCT income_statement (quarterly, 2025-09-30) — Net Interest Income: -7068000.00
CHCT cash_flow (quarterly, 2025-09-30) — Net Investment Properties Purchase And Sale: -25712000.00
CHCT cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: 30000000.00
CHCT cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: 30000000.00
CHCT income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -7068000.00
CHCT cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: -57000.00
CHCT cash_flow (quarterly, 2025-09-30) — Net Other Investing Changes: 120000.00
CHCT balance_sheet (quarterly, 2025-09-30) — Net PPE: 3058000.00
CHCT balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 425340000.00
CHCT balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Assets: 3142000.00
CHCT income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 20866000.00
CHCT income_statement (quarterly, 2025-09-30) — Normalized Income: 2341520.00
CHCT balance_sheet (quarterly, 2025-09-30) — Notes Receivable: 3960000.00
CHCT cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 12722000.00
CHCT cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: 888000.00
CHCT income_statement (quarterly, 2025-09-30) — Operating Income: 9596000.00
CHCT income_statement (quarterly, 2025-09-30) — Operating Revenue: 31086000.00
CHCT balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 28471424.00
CHCT balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: -364701000.00
CHCT income_statement (quarterly, 2025-09-30) — Other Gand A: 2158000.00
CHCT income_statement (quarterly, 2025-09-30) — Other Income Expense: -888000.00
CHCT balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 1483000.00
CHCT cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: -913000.00
CHCT balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 5917000.00
CHCT balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 4419000.00
CHCT balance_sheet (quarterly, 2025-09-30) — Other Properties: 3058000.00
CHCT balance_sheet (quarterly, 2025-09-30) — Other Receivables: 7950000.00
CHCT income_statement (quarterly, 2025-09-30) — Otherunder Preferred Stock Dividend: 750000.00
CHCT balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 17205000.00
CHCT balance_sheet (quarterly, 2025-09-30) — Preferred Stock: 0.00
CHCT balance_sheet (quarterly, 2025-09-30) — Prepaid Assets: 2179000.00
CHCT income_statement (quarterly, 2025-09-30) — Pretax Income: 1640000.00
CHCT income_statement (quarterly, 2025-09-30) — Provision For Doubtful Accounts: 0.00
CHCT cash_flow (quarterly, 2025-09-30) — Provisionand Write Offof Assets: 0.00
CHCT cash_flow (quarterly, 2025-09-30) — Purchase Of Investment Properties: -26363000.00
CHCT balance_sheet (quarterly, 2025-09-30) — Receivables: 36644000.00
CHCT income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 5569000.00
CHCT income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 11263000.00
CHCT cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: 0.00
CHCT balance_sheet (quarterly, 2025-09-30) — Retained Earnings: 76349000.00
CHCT income_statement (quarterly, 2025-09-30) — Salaries And Wages: 2500000.00
CHCT cash_flow (quarterly, 2025-09-30) — Sale Of Investment Properties: 651000.00
CHCT income_statement (quarterly, 2025-09-30) — Selling General And Administration: 4658000.00
CHCT balance_sheet (quarterly, 2025-09-30) — Share Issued: 28471424.00
CHCT cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 2465000.00
CHCT balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 426823000.00
CHCT balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 425340000.00
CHCT income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: -186480.00
CHCT income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.21
CHCT balance_sheet (quarterly, 2025-09-30) — Total Assets: 987261000.00
CHCT balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 700961000.00
CHCT balance_sheet (quarterly, 2025-09-30) — Total Debt: 534141000.00
CHCT balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 426823000.00
CHCT income_statement (quarterly, 2025-09-30) — Total Expenses: 21490000.00
CHCT balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 560438000.00
CHCT balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 938850000.00
CHCT balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 282572000.00
CHCT income_statement (quarterly, 2025-09-30) — Total Unusual Items: -888000.00
CHCT income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: -888000.00
CHCT balance_sheet (quarterly, 2025-09-30) — Working Capital: -229455000.00
CHCT income_statement (annual, 2025-12-31) — +Operating Expense: 77305000.00
CHCT income_statement (quarterly, 2025-12-31) — +Operating Expense: 21492000.00
CHCT income_statement (annual, 2025-12-31) — +Total Revenue: 121195000.00
CHCT income_statement (quarterly, 2025-12-31) — +Total Revenue: 30946000.00
CHCT balance_sheet (annual, 2025-12-31) — Accounts Receivable: 25572000.00
CHCT balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 25572000.00
CHCT balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 717450000.00
CHCT balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 717450000.00
CHCT cash_flow (annual, 2025-12-31) — Amortization Cash Flow: 1330000.00
CHCT cash_flow (quarterly, 2025-12-31) — Amortization Cash Flow: 425000.00
CHCT cash_flow (annual, 2025-12-31) — Amortization Of Intangibles: 1330000.00
CHCT cash_flow (quarterly, 2025-12-31) — Amortization Of Intangibles: 425000.00
CHCT balance_sheet (annual, 2025-12-31) — Assets Held For Sale Current: 5265000.00
CHCT balance_sheet (quarterly, 2025-12-31) — Assets Held For Sale Current: 5265000.00
CHCT income_statement (annual, 2025-12-31) — Basic Average Shares: 26857000.00
CHCT income_statement (quarterly, 2025-12-31) — Basic Average Shares: 26953000.00
CHCT income_statement (annual, 2025-12-31) — Basic EPS: 0.08
CHCT income_statement (quarterly, 2025-12-31) — Basic EPS: 0.51
CHCT cash_flow (annual, 2025-12-31) — Beginning Cash Position: 4384000.00
CHCT cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 3383000.00
CHCT cash_flow (annual, 2025-12-31) — Capital Expenditure: -20524000.00
CHCT cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -6537000.00
CHCT cash_flow (annual, 2025-12-31) — Capital Expenditure Reported: -20524000.00
CHCT cash_flow (quarterly, 2025-12-31) — Capital Expenditure Reported: -6537000.00
CHCT balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 3996000.00
CHCT balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 3996000.00
CHCT balance_sheet (annual, 2025-12-31) — Capital Stock: 285000.00
CHCT balance_sheet (quarterly, 2025-12-31) — Capital Stock: 285000.00
CHCT balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 3340000.00
CHCT balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 3340000.00
CHCT balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 3340000.00
CHCT balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 3340000.00
CHCT cash_flow (annual, 2025-12-31) — Cash Dividends Paid: -53669000.00
CHCT cash_flow (quarterly, 2025-12-31) — Cash Dividends Paid: -13547000.00
CHCT cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: -9778000.00
CHCT cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -11547000.00
CHCT cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -47696000.00
CHCT cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -3996000.00
CHCT cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 56430000.00
CHCT cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 15500000.00
CHCT cash_flow (annual, 2025-12-31) — Change In Other Current Assets: 994000.00
CHCT cash_flow (quarterly, 2025-12-31) — Change In Other Current Assets: -221000.00
CHCT cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: -1382000.00
CHCT cash_flow (quarterly, 2025-12-31) — Change In Other Current Liabilities: 1459000.00
CHCT cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: -1219000.00
CHCT cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: -991000.00
CHCT cash_flow (annual, 2025-12-31) — Change In Working Capital: -1607000.00
CHCT cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 247000.00
CHCT cash_flow (annual, 2025-12-31) — Changes In Cash: -1044000.00
CHCT cash_flow (quarterly, 2025-12-31) — Changes In Cash: -43000.00
CHCT balance_sheet (annual, 2025-12-31) — Common Stock: 285000.00
CHCT balance_sheet (quarterly, 2025-12-31) — Common Stock: 285000.00
CHCT balance_sheet (annual, 2025-12-31) — Common Stock Equity: 429387000.00
CHCT balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 429387000.00
CHCT cash_flow (annual, 2025-12-31) — Common Stock Issuance: 0.00
CHCT cash_flow (quarterly, 2025-12-31) — Common Stock Issuance: 0.00
CHCT income_statement (annual, 2025-12-31) — Cost Of Revenue: 23624000.00
CHCT income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 6014000.00
CHCT balance_sheet (annual, 2025-12-31) — Current Assets: 47448000.00
CHCT balance_sheet (quarterly, 2025-12-31) — Current Assets: 47448000.00
CHCT balance_sheet (annual, 2025-12-31) — Current Debt: 258000000.00
CHCT balance_sheet (quarterly, 2025-12-31) — Current Debt: 258000000.00
CHCT balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 258000000.00
CHCT balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 258000000.00
CHCT balance_sheet (annual, 2025-12-31) — Current Deferred Liabilities: 6034000.00
CHCT balance_sheet (quarterly, 2025-12-31) — Current Deferred Liabilities: 6034000.00
CHCT balance_sheet (annual, 2025-12-31) — Current Deferred Revenue: 6034000.00
CHCT balance_sheet (quarterly, 2025-12-31) — Current Deferred Revenue: 6034000.00
CHCT balance_sheet (annual, 2025-12-31) — Current Liabilities: 278959000.00
CHCT balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 278959000.00
CHCT cash_flow (annual, 2025-12-31) — Deferred Income Tax: 23000.00
CHCT cash_flow (annual, 2025-12-31) — Deferred Tax: 23000.00
CHCT cash_flow (annual, 2025-12-31) — Depreciation: 43538000.00
CHCT cash_flow (quarterly, 2025-12-31) — Depreciation: 10814000.00
CHCT cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 44868000.00
CHCT cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 11239000.00
CHCT income_statement (annual, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 43538000.00
CHCT income_statement (quarterly, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 10814000.00
CHCT cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 44868000.00
CHCT cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 11239000.00
CHCT income_statement (annual, 2025-12-31) — Depreciation And Amortization In Income Statement: 43538000.00
CHCT income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 10814000.00
CHCT income_statement (annual, 2025-12-31) — Diluted Average Shares: 26857000.00
CHCT income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 26953000.00
CHCT income_statement (annual, 2025-12-31) — Diluted EPS: 0.08
CHCT income_statement (quarterly, 2025-12-31) — Diluted EPS: 0.51
CHCT income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 2080000.00
CHCT income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 13684000.00
CHCT income_statement (annual, 2025-12-31) — EBIT: 32103000.00
CHCT income_statement (quarterly, 2025-12-31) — EBIT: 21410000.00
CHCT income_statement (annual, 2025-12-31) — EBITDA: 76971000.00
CHCT income_statement (quarterly, 2025-12-31) — EBITDA: 32649000.00
CHCT cash_flow (annual, 2025-12-31) — End Cash Position: 3340000.00
CHCT cash_flow (quarterly, 2025-12-31) — End Cash Position: 3340000.00
CHCT balance_sheet (annual, 2025-12-31) — Financial Assets: 6691000.00
CHCT balance_sheet (quarterly, 2025-12-31) — Financial Assets: 6691000.00
CHCT cash_flow (annual, 2025-12-31) — Financing Cash Flow: -9778000.00
CHCT cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -11547000.00
CHCT cash_flow (annual, 2025-12-31) — Free Cash Flow: 35906000.00
CHCT cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 8963000.00
CHCT cash_flow (annual, 2025-12-31) — Gain Loss On Investment Securities: -11803000.00
CHCT cash_flow (quarterly, 2025-12-31) — Gain Loss On Investment Securities: -12051000.00
CHCT balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -379125000.00
CHCT balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -379125000.00
CHCT income_statement (annual, 2025-12-31) — General And Administrative Expense: 25095000.00
CHCT income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 10678000.00
CHCT balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 1307000.00
CHCT balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 1307000.00
CHCT balance_sheet (annual, 2025-12-31) — Gross PPE: 3035000.00
CHCT balance_sheet (quarterly, 2025-12-31) — Gross PPE: 3035000.00
CHCT income_statement (annual, 2025-12-31) — Gross Profit: 97571000.00